Development of effective subunit vaccines against enveloped viruses
Simons, K.; Helenius, A.; Morein, B.; Balcorova, J.; Sharp, M.
Progress in Clinical and Biological Research 47: 217-228
1980
ISSN/ISBN: 0361-7742 PMID: 6259665 Document Number: 166599
Document emailed within 1 workday
Related Documents
Berezin, V.E.; Zaĭdes, V.M.; Artamonov, A.F.; Isaeva, E.S.; Zhdanov, V.M. 1986: Solubilization of glycoproteins from enveloped viruses by detergents Biokhimiia 51(5): 808-815Haywood, A.M. 1990: Relationships between binding, phagocytosis and membrane fusion of enveloped viruses Progress in Clinical and Biological Research 343: 117-132
Kostiukov, V.I.; Iarov, A.I.; Zezerov, E.G. 1982: Structural protective antigens of viruses used for the development of a new type of chemical vaccines Voprosy Virusologii 1: 5-11
Berezin, V.E.; Zaĭdes, V.M.; Zhdanov, V.M. 1986: Glycoproteins of enveloped viruses. Isolation of purified preparations and evaluation of their immunogenic properties Voprosy Virusologii 31(3): 262-274
Ksenofontov, A.L.; Badun, G.A.; Fedorova, N.V.; Kordiukova, L.V. 2008: An approach the quantitative determination of the area of glycoprotein spikes at the surface of enveloped viruses Molekuliarnaia Biologiia 42(6): 1093-1096
Berezin, V.E.; Artamonov, A.F.; Isaeva, E.S.; Zaĭdes, V.M.; Zhdanov, V.M. 1986: Inhibition of the infectivity of enveloped viruses while retaining the specific biological activity of the viral proteins Voprosy Virusologii 31(4): 475-479
Citovsky, V.; Shoshani-Gilad, R.; Loyter, A. 1990: Involvement of osmotic forces in fusion of enveloped viruses with intact human erythrocytes: studies with Sendai and influenza virus particles Progress in Clinical and Biological Research 343: 133-145
Abalaka, J.O.A. 2005: Design, development and successful application of safe and effective HIV therapeutic and prophylactic vaccines Zhonghua Nan Ke Xue 11(1): 8-16
Robertson, B.H.; Erdman, D.D. 2000: Non-enveloped viruses transmitted by blood and blood products Developments in Biologicals 102: 29-35
Clark, T.G.; Cassidy-Hanley, D. 2005: Recombinant subunit vaccines: potentials and constraints Developments in Biologicals 121: 153-163
Hunsmann, G. 1985: Subunit vaccines against exogenous retroviruses: overview and perspectives Cancer Research 45(9 Suppl): 4691s-4693s
Gibson, W.; Irmiere, A. 1984: Selection of particles and proteins for use as human cytomegalovirus subunit vaccines Birth Defects Original Article Series 20(1): 305-324
Pincus, S.H.; Messer, K.G.; Cole, R.; Ireland, R.; VanCott, T.C.; Pinter, A.; Schwartz, D.H.; Graham, B.S.; Gorse, G.J. 1997: Vaccine-specific antibody responses induced by HIV-1 envelope subunit vaccines Journal of Immunology 158(7): 3511-3520
Keith, J.A.; Agostini Bigger, L.; Arthur, P.A.; Maes, E.; Daems, R. 2013: Delivering the promise of the Decade of Vaccines: opportunities and challenges in the development of high quality new vaccines Vaccine 31(Suppl 2): B184-B193
Morales, A.; Arias Salazar, J.; Salazar, Y.; García, A.; Arnoux, S.; Arancibia, A.; Deroche, Cèle.; Rey, E. 2003: A randomized controlled trial comparing split and subunit influenza vaccines in adults in Colombia Medicina 63(3): 197-204
Silva, R.F.; Finkelstein, A. 1990: Recombinant viruses as poultry vaccines Journal of Reproduction and Fertility. Supplement 41: 153-162
Howard, C.R.; Gray, L.; D'Mello, F.; Christopher, J.; Craske, J. 1998: Nucleic acid vaccines against hepatitis viruses Developments in Biological Standardization 92: 157-162
Pascual, D.W.; Powell, R.J.; Lewis, G.K.; Hone, D.M. 1997: Oral bacterial vaccine vectors for the delivery of subunit and nucleic acid vaccines to the organized lymphoid tissue of the intestine Behring Institute Mitteilungen 1997(98): 143-152
Langford, C.J. 1986: Live vaccinia viruses for the delivery of malaria vaccines Papua and New Guinea Medical Journal 29(1): 103-108
Adotevi, O.; Vingert, B.; Freyburger, L.; Shrikant, P.; Lone, Y-Chun.; Quintin-Colonna, Fçoise.; Haicheur, N.; Amessou, M.; Herbelin, Aé.; Langlade-Demoyen, P.; Fridman, W.H.; Lemonnier, Fçois.; Johannes, L.; Tartour, E. 2007: B subunit of Shiga toxin-based vaccines synergize with alpha-galactosylceramide to break tolerance against self antigen and elicit antiviral immunity Journal of Immunology 179(5): 3371-3379